Erlangen : E. Besold, 1879.

Berlin : A. Hirschwald, 1854.

Berlin : A. Hirschwald, 1872.

Paris : V. Adrien Delahaye, 1879.

Paris : Adrien Delahaye, 1873.

Paris : Société d’éditions scientifiques, 1895.

Gottingen : A. Rente, 1866.

Paris : Steinheil, 1896.

Londres : L’Auteur, 1834.

Paris : Steinheil, 1888.

Paris, [France] : J.B. Baillière, Libraire de l'Académie Impériale de Médicine, 1854.

Châtillon, France : Association Hommefleur, [date of publication not identified]

Rockville, Maryland : National Institute on Drug Abuse, 1986.

Rockville, Maryland : National Institute on Drug Abuse, 1988.

Svetlana Mastitskaya
Apr 8, 2020; 40:3052-3062
Systems/Circuits

Maintenance of cardiorespiratory homeostasis depends on autonomic reflexes controlled by neuronal circuits of the brainstem. The neurophysiology and neuroanatomy of these reflex pathways are well understood, however, the mechanisms and functional significance of autonomic circuit modulation by glial cells remain largely unknown. In the experiments conducted in male laboratory rats we show that astrocytes of the nucleus of the solitary tract (NTS), the brain area that receives and integrates sensory information from the heart and blood vessels, respond to incoming afferent inputs with [Ca²⁺]_i elevations. Astroglial [Ca²⁺]_i responses are triggered by transmitters released by vagal afferents, glutamate acting at AMPA receptors and 5-HT acting at 5-HT_2A receptors. In conscious freely behaving animals blockade of Ca²⁺-dependent vesicular release mechanisms in NTS astrocytes by virally driven expression of a dominant-negative SNARE protein (dnSNARE) increased baroreflex sensitivity by 70% (p < 0.001). This effect of compromised astroglial function was specific to the NTS as expression of dnSNARE in astrocytes of the ventrolateral brainstem had no effect. ATP is considered the principle gliotransmitter and is released by vesicular mechanisms blocked by dnSNARE expression. Consistent with this hypothesis, in anesthetized rats, pharmacological activation of P2Y₁ purinoceptors in the NTS decreased baroreflex gain by 40% (p = 0.031), whereas blockade of P2Y₁ receptors increased baroreflex gain by 57% (p = 0.018). These results suggest that glutamate and 5-HT, released by NTS afferent terminals, trigger Ca²⁺-dependent astroglial release of ATP to modulate baroreflex sensitivity via P2Y₁ receptors. These data add to the growing body of evidence supporting an active role of astrocytes in brain information processing.

SIGNIFICANCE STATEMENT Cardiorespiratory reflexes maintain autonomic balance and ensure cardiovascular health. Impaired baroreflex may contribute to the development of cardiovascular disease and serves as a robust predictor of cardiovascular and all-cause mortality. The data obtained in this study suggest that astrocytes are integral components of the brainstem mechanisms that process afferent information and modulate baroreflex sensitivity via the release of ATP. Any condition associated with higher levels of "ambient" ATP in the NTS would be expected to decrease baroreflex gain by the mechanism described here. As ATP is the primary signaling molecule of glial cells (astrocytes, microglia), responding to metabolic stress and inflammatory stimuli, our study suggests a plausible mechanism of how the central component of the baroreflex is affected in pathological conditions.

Autism spectrum disorder (ASD) is characterized partly by atypical attentional engagement, reflected in exaggerated and variable responses to sensory stimuli. Attentional engagement is known to be regulated by the locus ceruleus (LC). Moderate baseline LC activity globally dampens neural responsivity and is associated with adaptive deployment and narrowing of attention to task-relevant stimuli. In contrast, increased baseline LC activity enhances neural responsivity across cortex and widening of attention to environmental stimuli regardless of their task relevance. Given attentional atypicalities in ASD, this study is the first to evaluate whether, under different attentional task demands, individuals with ASD exhibit a different profile of LC activity compared with typically developing controls. Males and females with ASD and age- and gender-matched controls participated in a one-back letter detection test while task-evoked pupillary responses, an established correlate for LC activity, were recorded. Participants completed this task in two conditions, either in the absence or presence of distractor auditory tones. Compared with controls, individuals with ASD evinced atypical pupillary responses in the presence versus absence of distractors. Notably, this atypical pupillary profile was evident despite the fact that both groups exhibited equivalent task performance. Moreover, between-group differences in pupillary responses were observed specifically in response to task-relevant events, providing confirmation that the group differences most likely were specifically associated with distinctions in LC activity. These findings suggest that individuals with ASD show atypical modulation of LC activity with changes in attentional demands, offering a possible mechanistic and neurobiological account for attentional atypicalities in ASD.

SIGNIFICANCE STATEMENT Individuals with autism spectrum disorder (ASD) exhibit atypical attentional behaviors, including altered sensory responses and atypical fixedness, but the neural mechanism underlying these behaviors remains elusive. One candidate mechanism is atypical locus ceruleus (LC) activity, as the LC plays a critical role in attentional modulation. Specifically, LC activity is involved in regulating the trade-off between environmental exploration and focused attention. This study shows that, under tightly controlled conditions, task-evoked pupil responses, an LC activity proxy, are lower in individuals with ASD than in controls, but only in the presence of task-irrelevant stimuli. This suggests that individuals with ASD evince atypical modulation of LC activity in accordance with changes in attentional demands, offering a mechanistic account for attentional atypicalities in ASD.

Acute myeloid leukemia is an aggressive cancer of the blood-forming system. It affects the hematopoietic stem cells, or blood stem cells, of various white blood cells and of the red blood cells and platelets.

The quinoline MK-571 is the most commonly used inhibitor of multidrug resistance protein-1 (MRP-1) but was originally developed as a cysteinyl leukotriene receptor 1 (CysLTR1) antagonist. While studying the modulatory effect of MRP-1 on anti-hepatitis C virus (HCV) direct acting-antivirals (DAA) efficiency, we observed an unexpected anti-HCV effect of compound MK-571 alone. This anti-HCV activity was characterized in Huh7.5 cells stably harboring a subgenomic genotype 1b replicon. A dose-dependent decrease of HCV RNA levels was observed upon MK-571 administration, with an EC₅₀ of 9±0.3 μM and a maximum HCV RNA level reduction of approximatively 1 Log₁₀. MK-571 also reduced the replication of the HCV full-length J6/JFH1 model in a dose-dependent manner. However, probenecid and apigenin homodimer (APN), two specific inhibitors of MRP-1, had no effect on HCV replication. In contrast, the CysLTR1 antagonists SR2640 increased HCV-SGR RNA levels in a dose-dependent manner, with a maximum increase of 10-fold. In addition, a combination of natural CysLTR1 agonist (LTD4) or antagonists (zafirlukast, cinalukast, and SR2640) with MK-571 completely reversed its antiviral effect, suggesting its anti-HCV activity is related to CysLTR1 rather to MRP-1 inhibition. In conclusion, we showed that MK-571 inhibits HCV replication in hepatoma cell cultures by acting as a CysLTR1 receptor antagonist, thus unraveling a new host-virus interaction in the HCV life cycle.

1 Seychellois Rupee = 0.2594 Romanian Leu

1 Seychellois Rupee = 1.0386 Moldovan Leu

1 Trinidad and Tobago Dollar = 0.659 Romanian Leu

1 Trinidad and Tobago Dollar = 2.6387 Moldovan Leu

1 Swedish Krona = 0.4557 Romanian Leu

1 Swedish Krona = 1.8247 Moldovan Leu

1 Slovak Koruna = 0.2005 Romanian Leu

1 Slovak Koruna = 0.803 Moldovan Leu

1 Serbian Dinar = 0.0411 Romanian Leu

1 Serbian Dinar = 0.1644 Moldovan Leu

1 Polish Zloty = 1.0591 Romanian Leu

1 Polish Zloty = 4.2407 Moldovan Leu

1 Qatari Rial = 1.2231 Romanian Leu

1 Qatari Rial = 4.8973 Moldovan Leu

1 Indian Rupee = 0.059 Romanian Leu

1 Indian Rupee = 0.2362 Moldovan Leu

1 Pakistani Rupee = 0.0279 Romanian Leu

1 Pakistani Rupee = 0.1117 Moldovan Leu

1 Sierra Leonean Leone = 0.0005 Romanian Leu

1 Sierra Leonean Leone = 0.0018 Moldovan Leu

1 New Taiwan Dollar = 0.1492 Romanian Leu

1 New Taiwan Dollar = 0.5972 Moldovan Leu

1 Thai Baht = 0.1391 Romanian Leu

1 Thai Baht = 0.5569 Moldovan Leu

1 Turkish Lira = 0.6282 Romanian Leu

1 Turkish Lira = 2.5153 Moldovan Leu

1 Singapore Dollar = 3.1524 Romanian Leu

1 Singapore Dollar = 12.6221 Moldovan Leu

1 Mauritian Rupee = 0.1121 Romanian Leu

1 Mauritian Rupee = 0.449 Moldovan Leu

1 Nepalese Rupee = 0.0368 Romanian Leu